Completed NA INTERVENTIONAL 2-arm NCT04738474

Assessing and Promoting Resilience in Patients With Adult Congenital Heart Disease (PRISMACHD)

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Interventions Promoting Resilience in Stress Management (PRISM) Usual Care

Updated 9 times since 2021 Last updated: Nov 19, 2025 Started: Mar 15, 2023 Primary completion: Jul 25, 2024 Completion: Jul 25, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Congenital Heart Disease, this trial is completed. The trial is conducted by National Heart, Lung, and Blood Institute (NHLBI) and has accumulated 9 data snapshots since 2023. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

9 versions recorded

Jan 2026 — Present [monthly]

Completed NA
Nov 2025 — Jan 2026 [monthly]

Completed NA
Sep 2024 — Nov 2025 [monthly]

Completed NA

Status: Recruiting → Completed
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Feb 2024 — Jul 2024 [monthly]

Recruiting NA

▶ Show 4 earlier versions

Nov 2023 — Feb 2024 [monthly]

Recruiting NA
Jun 2023 — Nov 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Dec 2022 — Jun 2023 [monthly]

Not Yet Recruiting NA
Mar 2021 — Dec 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Heart, Lung, and Blood Institute (NHLBI)
University of Washington

Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States